Latest Conference Articles
Addressing Cancer Disparities Requires Asking Questions and Putting Aside Assumptions
September 28th 2020, 6:39pm
Patient-Centered Oncology Care
Speakers at Patient-Centered Oncology Care® highlighted injustices in the US health care system, the risk of financial toxicity, and how providers can do a better job to ensure their patients achieve health equity, during a panel discussion.
Infrastructure of OCM Helps Practices Through COVID-19, Chong Says
September 28th 2020, 1:00pm
Patient-Centered Oncology Care
CMMI's Alexandra Chong, PhD, discusses COVID-19 related flexibilities under the Oncology Care Model, and a panel discusses its successor.
Dr Kerin Adelson Discusses Evolution in Physician Response to Quality Care Initiatives
September 27th 2020, 1:00pm
Patient-Centered Oncology Care
A gradual acceptance among physicians has been observed in adopting quality care initiatives that provide cost-saving, improved patient experience in cancer care, noted Kerin Adelson, MD, of Smilow Cancer Hospital at Yale New Haven/Yale Cancer Center.
Dr Kassandra Munger on Vitamin D and Multiple Sclerosis
September 26th 2020, 6:00pm
ECTRIMS: European Committee for Research and Treatment in Multiple Sclerosis
Kassandra Munger, ScD, of the Harvard TH Chan School of Public Health, discusses findings that vitamin D deficiencies are linked to a greater risk of multiple sclerosis.
Dr Patricia Coyle: Ofatumumab Has the Benefit of Being Taken at Home
September 26th 2020, 6:00pm
ECTRIMS: European Committee for Research and Treatment in Multiple Sclerosis
The biggest difference between ocrelizumab and the recently approved ofatumumab is that ofatumumab can be taken at home for relapsing forms of multiple sclerosis (MS), explained Patricia K. Coyle, MD.
Researchers Hope Goal of Myelin Repair Is Closer Even With Poor Trial Results
September 26th 2020, 3:50pm
ECTRIMS: European Committee for Research and Treatment in Multiple Sclerosis
Researchers hope that a more targeted retinoid acid X receptor compound could repair myelin without the adverse effects seen in every patient in this trial, which tested an already approved cancer drug.
Dr Harlan Levine on City of Hope's Efforts to Address COVID-19 in Cancer Care
September 26th 2020, 1:00pm
Patient-Centered Oncology Care
Testing for coronavirus disease 2019 (COVID-19) before procedures has become a fixture of City of Hope's efforts to protect patients with cancer and staff, noted Harlan Levine, MD, president of Strategy and Business Ventures at City of Hope.
Dr David Debono Details Anthem's Value-Based Strategy in Cancer Care
September 25th 2020, 7:55pm
Patient-Centered Oncology Care
Aligned with ASCO's Patient-Centered Oncology Payment model, Anthem has launched its value-based strategy called the oncology medical home, which seeks to promote quality metrics and improve outcome measures in cancer care.
Dr Burcu Zeydan Explains Why DMTs Become Less Effective as Patients Age
September 24th 2020, 9:00pm
ECTRIMS: European Committee for Research and Treatment in Multiple Sclerosis
Disease-modifying therapies (DMTs) are primarily effective through immunomodulation, in that they target relapse prevention, said Burcu Zeydan, MD, assistant professor of neurology, assistant professor of radiology, at Mayo Clinic.
Dr Joseph Alvarnas on Pressing Topics Within Clinical Pathways to be Discussed at PCOC® 2020
September 24th 2020, 8:09pm
Patient-Centered Oncology Care
Progress within the adoption of clinical pathways, particularly in achieving standardization in cancer care, will be further discussed at Patient-Centered Oncology Care 2020®.